Skip to Main Content

Paper Details

Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.
Dig Dis
1
2023
ALD, Alcoholic Liver Disease, Alcoholic liver disease, HCC, Patient, Patients, acetylsalicylic acid, aspirin, carvedilol, catecholamines, dobutamine, dopamine, hepatocellular carcinoma, liver cirrhosis, liver failure, metformin, metoprolol, patient, patients
Author NameAffiliation
Thomas FalconerColumbia University Irving Medical Center
Thomas FalconerColumbia University Irving Medical Center
Joo Hun ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
George HripcsakColumbia University Irving Medical Center
George HripcsakColumbia University Irving Medical Center
  • 1 - 9

Datasets

Release 1.2